Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | SVP, Cont & Chief Acct Officer | June 26, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date June 26, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 27,606 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Tax withholding · Disposed 454 · Balance 27,606 F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jun 29, 2026 19:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (Restricted) | 454 | $90.98 | $41,304.92 |
DisclosureSEC source: 0000064803-26-000092 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,606 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,262 | $72.49 | $236,462.38 |
DisclosureSEC source: 0000064803-26-000036 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,457 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 11,976 | $71.82 Strike: $71.82 | $860,116.32 |
DisclosureSEC source: 0000064803-26-000036 · form4.xml · derivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,976 Underlying: Common Stock · 11,976 shares Expires 2036-03-31 F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 11,138 | $71.82 | $799,931.16 |
DisclosureSEC source: 0000064803-26-000036 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,539 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 23:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (Restricted) | 220 | $79.10 | $17,402.00 |
DisclosureSEC source: 0000064803-25-000079 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,401 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 14,710 | $67.98 | $999,985.80 |
DisclosureSEC source: 0001127602-25-011394 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,707 F2 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,266 | $67.98 | $154,042.68 |
DisclosureSEC source: 0001127602-25-011394 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,240 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 7,513 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-25-008726 · form4.xml · derivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,513 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 7,513 | $66.35 | $498,487.55 |
DisclosureSEC source: 0001127602-25-008726 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,394 Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 7,513 | $62.21 | $467,383.73 |
DisclosureSEC source: 0001127602-25-008726 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 22:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 86 | $59.85 | $5,147.10 |
DisclosureSEC source: 0001127602-24-028492 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,394 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 10,683 | $79.56 | $849,939.48 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,109 F3 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,112 | $79.56 | $88,470.72 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,480 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,892 | $79.56 | $150,527.52 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,592 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005071 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,150 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (Restricted) | 122 | $68.48 | $8,354.56 |
DisclosureSEC source: 0001127602-23-029716 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,760 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 23,128 | $74.94 | $1,733,212.32 |
DisclosureSEC source: 0001127602-23-022036 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,698 F2 · price: Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,631.255 | $74.79 | $196,791.56 |
DisclosureSEC source: 0001127602-23-022036 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,826 F1 · price: Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 9,649 | $74.31 Strike: $74.31 | $717,017.19 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · derivative · entry 10 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,649 Underlying: Common Stock · 9,649 shares Expires 2033-04-01 F11 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 2,186 | $74.31 | $162,441.66 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,080 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,471 | $74.31 | $109,310.01 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,457.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 179 | $83.54 | $14,953.66 |
DisclosureSEC source: 0001127602-23-007949 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,151.2554 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 153 | $101.65 | $15,552.45 |
DisclosureSEC source: 0001127602-22-026782 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,177.2554 F1 · shares: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 6,756 | $101.09 Strike: $101.09 | $682,964.04 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,756 Underlying: Common Stock · 6,756 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,214 | $101.09 | $324,903.26 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,824 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,740 | $101.09 | $276,986.60 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,330.2554 F2 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,897 | $101.09 | $393,947.73 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 253 | $103.65 | $26,223.45 |
DisclosureSEC source: 0001127602-22-007421 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,668.2554 F2 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 183 | $103.65 | $18,967.95 |
DisclosureSEC source: 0001127602-22-007421 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,334.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 8,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006287 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,092.2554 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,059 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,059 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options became exercisable in four equal annual installments beginning on 4/1/2016. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,059 | $109.00 | $660,431.00 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,497.2554 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,059 | $102.26 | $619,593.34 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,556.2554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (restricted) | 68 | $88.78 | $6,037.04 |
DisclosureSEC source: 0001127602-21-030254 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,921 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| December 01, 2021 Filed Oct 14, 2022 21:52 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock (restricted) | 266 | $88.78 | $23,615.48 |
DisclosureSEC source: 0001127602-22-023944 · form4a.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,723 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| April 03, 2021 Filed Apr 5, 2021 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 480 | $74.30 | $35,664.00 |
DisclosureSEC source: 0001127602-21-013218 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,497.2554 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 3, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 12,094 | $74.30 Strike: $74.30 | $898,584.20 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · derivative · entry 5 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Underlying: Common Stock · 12,094 shares Expires 2031-04-01 F5 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,710 | $74.30 | $349,953.00 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,046 F4 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,503 | $74.30 | $111,672.90 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,920.2554 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 5,246 | $74.30 | $389,777.80 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,111.2554 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,350 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-21-012633 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,350 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,350 | $76.00 | $406,600.00 |
DisclosureSEC source: 0001127602-21-012633 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,244.2554 F1 · kind: All sales were effective pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,350 | $74.29 | $397,451.50 |
DisclosureSEC source: 0001127602-21-012633 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,594.2554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,129 | $68.13 | $76,918.77 |
DisclosureSEC source: 0001127602-21-008769 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,244.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 01, 2021 Filed Apr 2, 2021 21:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 13,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,930.2554 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 270 | $65.00 | $17,550.00 |
DisclosureSEC source: 0001127602-20-018059 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,547.2554 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,234 | $65.00 | $405,210.00 |
DisclosureSEC source: 0001127602-20-014867 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,817.2554 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 17,157 | $58.34 Strike: $58.34 | $1,000,939.38 |
DisclosureSEC source: 0001127602-20-013238 · form4.xml · derivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,157 Underlying: Common Stock · 17,157 shares Expires 2030-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 7,713 | $58.34 | $449,976.42 |
DisclosureSEC source: 0001127602-20-013238 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,204 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 681 | $58.34 | $39,729.54 |
DisclosureSEC source: 0001127602-20-013238 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,321.2554 F1 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.